<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="the European Union,1 the guide â€œHuman Tissue Actâ€� of the" exact="United Kingdom" post="(Human Tissue 2020; Human Tissue Authority 2020), and â€œHuman"/>
 <result pre="Productsâ€� (Code of Federal Regulations Title 21 2020) of the" exact="United States" post="Federal Drug Administration. In Chile, this area is under"/>
 <result pre="year 1983)â€� (Ley NÂ° 1996) which was published in 1996." exact="Chile" post="has been employed to present a case study from"/>
 <result pre="deceased donor with brain death (DBD), a process known in" exact="Chile" post="as â€œLast will testimony requestâ€�, which is carried out"/>
 <result pre="2018; Tallentire 1990), which has been a successful partnership after" exact="Chile" post="joined the Latin American Association of Tissue Banks (ALABAT)"/>
 <result pre="of patients outside the health explicit guaranties coverage (e.g. in" exact="Chile" post="most known as GES-AUGE pathologies) or outside of insurance"/>
 <result pre="financial stimuli associated with performance. For example, the ISP from" exact="Chile" post="can enhance this development through activity plans in conjunction"/>
 <result pre="years of a developing country case study example, such as" exact="Chile" post="with its tissue transplants services implementation and taking into"/>
 <result pre="acknowledge funding from CorporaciÃ³n de Fomento de la ProducciÃ³n de" exact="Chile" post="(CORFO, grant number 18IIP-BB-99543) and the Royal Society of"/>
 <result pre="cellular and tissue-based products, Code of Federal Regulations Title 21," exact="United States" post="Food and Drug Administration. Website: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271. Accessed on May"/>
 <result pre="of disposable medical products. IAEA-TECDOC-539. International Atomic Energy Agency, Vienna," exact="Austria" post="TaylorDMInactivation of prions by physical and chemical meansJ Hosp"/>
</results>
